Rac1 was reported to be overexpressed or hyperactivated in breast cancer, as well as in other various cancers, including prostate, testicular, ovarian, lung and gastric cancers (Bos et al. 2007; Casado-Medrano et al. 2018). Here, RAC1 is linked to breast cancer.